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ABSTRACT
Nowadays, the development of drug-loaded electrospun organic-inorganic composite scaffolds for tissue
engineering application is an attractive approach. In this study, a composite scaffold of Poly-l-lactic acid (PLLA)
incorporated dexamethasone (Dexa) loaded Mesoporous Silica Nanoparticles (MSN) coated with Chitosan (CS)
were fabricated by electrospinning for bone tissue engineering application. The MSN was prepared by precipi-
tation method. After that, Dexamethasone (Dexa) was loaded into MSNs (MSN-Dexa). In the following, CS was
coated over the prepared nanoparticles to form MSN-Dexa@CS and then, were mixed to PLLA solution to
form MSN-Dexa@CS/PLLA composite for electrospinning. The surface morphology, hydrophilicity, tensile
strength and the bioactivity of the scaffolds were characterized. The osteogenic proliferation and differenti-
ation potential were evaluated by MTT assay and by measuring the basic osteogenic markers: the activity of
the enzyme alkaline phosphatase and the level of calcium deposition. The composite scaffolds prepared here
have conductive surface property and have a better osteogenic potential than pure PLLA scaffolds. Hence, the
controlled release of nanoparticle containing Dexa from composite scaffold supported the osteogenesis and
made the composite scaffolds ideal candidates for bone tissue engineering application and pH-sensitive
delivery of drugs at the site of implantation in tissue regeneration.
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Introduction
Tissue engineering (TE) is a multidisciplinary science which
brings the best alternative to conventional therapies to repair
damaged tissues [1]. For effective regeneration or repair of the
damaged tissue, TE involves combination of various factors to
mimic the natural structure of damaged tissue. The three crit-
ical components commonly referred to as the “tissue engineer-
ing triad”, are scaffolds, cells, and growth factors [1,2]. The
scaffold is the key component in TE due to providing struc-
tural support for the cells to adhere, grow, spread, proliferate
and penetrate moreover the scaffolds can trigger maturation
and phenotypic expression in the cells by facilitating diffusion
of nutrients and growth factors localized delivery [3]. In add-
ition, it could also be used to deliver drugs that can accelerate
the regenerative and healing process [4,5]. Several materials of
both natural and synthetic origin have been investigated for
fabrication of TE scaffolds, [6] including; metals, ceramics, poly-
mers [3] and composites [7].
Among the synthetic polymers, Poly-l-lactic acid (PLLA) has
been widely used for making scaffolds for bone tissue engin-
eering. This is because of its superior mechanical properties,
biodegradability, and biocompatibility with high spatial inter-
connectivity, high porosity, and controlled alignment electro-
spun 3D nanofibrous matrices provide cell migration ability
[8,9]. Moreover, it is an FDA approved polymer for various bio-
medical applications including drug delivery and TE [10]. In
spite of that; the scaffolds made of pure PLLA, have low bio-
logical activity and poor mechanical strength, hampering their
applications in bone TE. In addition, it’s in vivo acidic degrad-
ation products may cause inflammatory and allergic reactions
at the site of implantation [11]. Besides, scaffolds made
from polymers are generally flexible, can be easily fabricated
to form complex shapes and structures but lack of mechanical
strength and bioactive function (e.g. strong bonding to living
tissue). While ceramics and glasses are known as too stiff
and brittle. Hence, the development of composite materials
for TE scaffolds is nowadays an attractive approach. Since
scaffold properties can be modified to the particular mechan-
ical and physiologic demands of the host tissue [12,13].
Currently, bioactive calcium phosphate-based biomaterials
and bioceramics have been frequently used as a composite
to reinforce the biopolymers including PLLA with
mechanical property, bioactivity and better osteoconductiv-
ity [11].
Targeting drug delivery system and gene therapy have
been impressed by the superior attributes of mesoporous sil-
ica nanoparticles (MSNs). The conspicuous virtues of MSN
including large surface areas, high pore volumes, tunable
pore diameters, the surface capability of being modified with
various functional groups, and biocompatibility stand out to
be a promising candidate for biomedical application [14–16].
Moreover, surface functional groups of MSN can participate
in specific chemical reactions such as body fluids to generate
nano-sized carbonated apatite in order to ensure the integra-
tion of implanted bone by bioactive binding to natural bone
[17]. In addition, the type 1 collagen (COL 1) synthesis,
expression of osteogenic related genes in osteoblasts and
formation of mineralized nodule promoted by silicon ions
released from MSNs [18]. The mechanical interlocking
between MSNs and a given polymer due to high porosity of
MSNs could form strong bond to decrease adhesion problem
with other varieties of reinforcement materials. In addition to
this, the efficient stress transfer mechanism as a consequence
of high surface area nature of MSNs could lead to increasing
the strength of MSN/polymer composites [19]. As mentioned
above, bone TE has been impressed by the advantages of
MSNs as implantable material and stand out to be a promis-
ing candidate [18].
The chemical flexibility with the ability to load various
classes of drugs highlights MSNs as incredible system for cell-
targeted uptake and controlled drug delivery [20–22]. MSNs
incorporation in scaffolds can provide refined drug delivery
system for targeted and controlled drug delivery system in
biological cues. The unique features of MSN such as tunable
size and shape, high pore volume and large surface area pro-
vide facilities to high drug loading. In addition, MSNs plat-
form flexibility and the possibilities to modify surface
functional groups made this kind of platform appropriate for
targeted and controlled release of drugs. The advantages of
the MSNs surface functionalization can be summarized as fol-
lows: circumvention of undesirable biological interaction and
promotion desirable one by precise engineering, enhance-
ment of bioavailability and cellular uptake. Apart from
these, biomaterial mechanical properties, prolonged and
sustained release profile and intracellular gene delivery in
bone TE would be improved by MSNs. Altogether these
advantages make it possible to customize therapeutic action
by targeted and controlled drug delivery and tailored
pharmacokinetic and release profile in tissue regener-
ation [23].
Dexamethasone (Dexa) induces osteoblast differentiation
in typical time and dose-dependent manners [24]. More
importantly, Dexa exerts its osteoactivity via binding to the
glucocorticoid receptor within the cellular cytosol [25].
Therefore, to promote osteoblast differentiation efficacy,
Dexa must be transported intracellularly and then release in
a controlled manner. However, the “premature release” often
limits the efficacy and undesirably increases the dosage of
Dexa. Simultaneously transport Dexa into the cell and further
release it in the cytosol [26,27].
Chitosan (CS), with a strong response in near-neutral or
slightly acidic pH ranges, has been used utilized as a good
candidate for pH-sensitive MSNs-based drug delivery [28,29].
In addition, CS can stimulate osteoconductivity and enhance
mineralization [30]. Therefore, we hypothesize that CS coated
MSNs (MSN@CS) may be a promising nanocarrier for targeted
delivery of Dexa. Based on the above rationale in this work,
MSN-Dexa@CS/PLLA composite electrospun scaffolds were
fabricated to enhance bone regeneration. We first loaded
Dexa into the MSNs (MSN-Dexa) and then, the CS was coated
on the surface of MSNs (MSN-Dexa@CS) and finally, mixed
with PLLA solution to form MSN-Dexa@CS/PLLA composite
for electrospinning. In this ensemble, CS physically capped
onto the outlet of the MSNs was as a “gate-like” ensemble to
achieve pH-sensitive release of loaded Dexa within the cell.
After being endocytosed into cells, with the decreasing of
the pH value and the changing of dispersing states of the
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CS, the loaded Dexa will then release into the cytosol [31].
Consequently, Dexa exerted osteoblast differentiation
effects [31].
Material and methods
Materials
Cetyltrimethylammonium bromide (CTAB), Tetraethyl orthosi-
licate (TEOS), Mesitylene and all other solvents and reagents
were purchased from Merck (Darmstadt, Germany).
Dexamethasone and dimethyl sulfoxide (DMSO) were from
Merck (Darmstadt, Germany). MTT solution and Ascorbic acid
2-phosphate and b-glycerophosphate were purchased from
Sigma-Aldrich, St. Louis, MO.
Preparation of MSN
MSNs were prepared in the presence of mesitylene based on
previous procedures [32,33]. Briefly, 7.0ml of mesitylene, as a
swelling agent of micelles, and 1.0 g of CTAB were added to
a solution containing 480ml of deionized water and 3.5ml of
NaOH (2M). The solution was stirred vigorously at 80 C for
4 h and then 5.0ml of TEOS was quickly added into the solu-
tion. After vigorous stirring at 80 C for another 2 h, the pre-
pared white precipitate was collected by vacuum filtrations
and washed several times with ethanol. In order to form
MSN as a white powder, the washed precipitation dried over-
night under vacuum at 45 C. The template CTAB (surfactant)
in MSN was removed by heating the powder at 550 C in air
for 3 h. In order to verify the successful calcination of MSN, IR
spectroscopy was used to reveal presence of any residual
organic species.
Dexa loading into MSN
Dexa was loaded into the MSN according to reported proce-
dures with some modifications [33,34]. Briefly, 50mg MSN was
added into 5ml Dexa solution in distilled water at a concentra-
tion of 2mg/ml. In order to obtain well-dispersed suspension,
prepared mixture was ultrasonically dispersed for 5min by
bath sonicator and stirred at room temperature for 48h.
Afterward, the dispersion was centrifuged to collect Dexa
loaded nanoparticles and then washed with deionized water.
In order to calculate Dexa loading efficiency (DLE) and Dexa
loading capacity (DLC), the supernatant was preserved and
residual Dexa in supernatant was analyzed through plotting
calibration curve of Dexa standard solutions by UV-visible
spectroscopy at the wavelength of 243nm. The Dexa loading
efficiency and capacity were evaluated using following
formulas:
DLE ð%Þ ¼ mass of loaded Dexa in MSN=
total mass of Dexa added initially 100
DLC ð%Þ ¼ mass of loaded Dexa in MSN=
mass of MSN 100
Preparation of CS coated MSNs
We used a reported procedure with some modification to
coat CS on the surface of MSN [35] as follows; 125mg CS
was dispersed in 25ml acetic acid (3%) and stirred for 24 h to
obtain a solution of CS (0.5% w/v). 50mg of Dexa loaded
MSN was added in 25ml ethanol, the mixture was dispersed
for 5min and then the pH was adjusted to 3.5–4.5 by add-
ition of acetic acid. Consequently, 5ml of the CS solution was
added drop wisely to the above mixture of Dexa loaded MSN
and stirred at room temperature for 24 h. Finally, the mixture
was centrifuged at 10,000 rpm to collect CS coated MSN,
washed twice with deionized water and excess ethanol, and
dried overnight under vacuum at room temperature.
Electrospinning fabrication of different scaffolds
PLLA scaffolds were prepared by dissolving 0.43 g of PLLA in
6ml of chloroform and continuously stirred under magnetic
stirrer at 200 rpm until all the PLLA was completely dissolved.
For composite scaffolds, 5% w/v of CS coated MSN (Dexa
loaded and unloaded into two separated part) was first dis-
solved in 1ml of DMF by sonication for 2min and then
added to the above PLLA solution under stirring till the bub-
ble-free transparent solution was formed. The solution was
then transferred to two 5 cc syringe with needle to automatic
syringe pump. One-step two nozzles electrospinning was
used to fabricate the scaffolds. The Nano Model (Tehran,
Iran) with two nozzles was used to setup electrospinning
experimental. The voltage applied at the tip of the needle
was 20 kV. The mass flow rates were 0.5ml/h, and distance
between the tip of the needle and the collector was main-
tained at 15 cm. The speed of the rotary collector was
500 rpm and scanning distance was 10 cm. The nanofibrous
scaffolds were air plasma treated with Diener electronic
plasma cleaner (Germany).
Water contact assay
It was evaluated by using sessile drop water contact angle
measurement (OCA 15 plus) Surface Analysis system. A drop
of water was placed on the nanofibrous scaffolds and after
10 s the contact angle was measured at room temperature.
Tensile strength assay
In order to measure the nanofibrous scaffolds’ tensile
strength, the specimens of different kind of scaffolds with
30mm gauge length and 5mm diameter were held on the
surfaces by clips and placed into the tensile tester. The ten-
sile measurement was done at 50mm/min crushing speed.
Isolation and expansion of human adipose tissue-
derived mesenchymal stem cell (MSCs)
Isolation of MSCs from human adipose tissue was achieved
according to the previous protocol [36]. The adipose tissue
was taken from cosmetic liposuction of 10 different donors
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(age 24–40, Shariati, Hospital, Tehran, Iran) after the full con-
sent of each person according to the guidelines of Iran’s
Ministry of Health Medical Ethics Committee. The adipose tis-
sue was then treated with collagenase 1% and trypsin 25%
(GIBCO) with shaking at 37 C in an incubator for 30min and
then centrifuged, and the cell pellet was resuspended in
Dulbecco’s Modified Eagle’s Medium (DMEM) containing 10%
(v/v) fetal bovine serum (FBS), transferred to the flasks and
put in to an incubator until reaching 80% confluence, the
cell was subcultured till passage number five.
Cell seeding
To seed cell, the scaffolds were cut in to 1.5 diameter circular
pieces, put in to 24-well tissue culture plate (TCP), sterilized
with 70% ethanol, washed with phosphate-buffered saline
(PBS, pH 7.4) twice and finally, incubated with basal medium
(DMEM supplemented with 10% FBS) including antibiotics.
An initial density of 5 103 cells was seeded on each scaffold
for assessment of cell attachment and proliferation. For
osteogenic differentiation evaluations, basal medium was
supplemented with 100 nM Dexa, 0.2mM ascorbic acid
2-phosphate and 10mM b-glycerophosphate and placed on
the cell-loaded scaffolds after seeding an initial density of
104 cells followed by reaching 80% confluence. Dexa was
excluded from the osteogenic media for Dexa
loaded scaffold.
Cell proliferation
The affinity of the cell for the new nanofiber scaffold which
is defined with adhesion and proliferation of cultured stem
cells on the scaffold was investigated through MTT assay. For
this purpose, the incubated cell-loaded scaffolds were
refreshed with DMEM including 10% MTT solution after 24 h
for cell adhesion and on days 1, 4, and 7 for cell proliferation
assay and incubated again for 3–4 h in order to oxidize this
substrate in the living cells by mitochondrial dehydrogenases.
Then the supernatant was replaced with DMSO as the solv-
ent of the dark blue formazan crystals formed in the live cells
and finally the absorbance of purple solution was measured
via spectrophotometer (Bioteck, Winooski, VT) at 570 nm.
Alkaline phosphatase activity (ALP)
ALP activity is an early marker of osteogenic differentiation of
human MSCs. ALP activity was determined by a colorimetric
method using Phosphatase Substrate Kit which contains P-
Nitro Phenyl Phosphate (PNPP) as a substrate. Briefly, 250ml
Radioimmunoprecipitation assay buffer (RIPA buffer) and pro-
tease inhibitor were used in order to extract the total protein
of cells and prevent the extracted proteins from degradation.
The lysate was shaken at 4 C and centrifuged at 15,000 rpm
for 15min to sediment cell debris. Finally the supernatant
was collected and the ALP assay kit (Parsazmoon, Tehran,
Iran) was used to measure the activity of ALP. The activity of
enzyme (IU/L) was normalized against total protein (mg/dl).
Calcium content assay
To determine the extent of mineralization: first, the cell
loaded scaffolds were homogenized in 0.6 N HCl and then
shaken at 4 C for 1 h in order to extract the calcium depos-
ited. Finally, the calcium content was calculated through a
calcium content assay kit (Parsazmoon, Tehran, Iran) and cre-
solphthalein complexone interaction. Furthermore, the stand-
ard curve of OD versus concentration was estimated by using
a serial dilution of standard solution in the kit.
Statistical analysis
All experiments were conducted at least three times, and the
values were reported as the mean± standard deviation.
Statistical analysis was conducted by two-way analysis of vari-
ance (two-way ANOVA), a value of p< .05 was considered as
statistically significant.
Characterization
Fourier transform infrared spectroscopy (FTIR) were taken by
FT-IR Magna 550, Nicolet using the KBr plates to investigate
functional groups of nanoparticles. Powder XRD patterns
were collected on STOE Theta-theta Powder Diffraction
System, Radiation: 1.54060 Cu, Generator: 40 kV, 40mA.
UV–visible spectra results were obtained using UV–visible
Jasco-530 spectrophotometer and via spectrophotometer
(Bioteck, Winooski, VT). The morphology of the samples was
investigated by transmission electron microscope (HRTEM,
Philips CM30, 300 kV, Netherlands) and field emission scan-
ning electron microscope (FE-SEM, Tescan/Mira, Czech
Republic). Scanning electron microscope (SEM) was used to
determine the surface morphology of the nanofibrous scaf-
folds. Thermogravimetric analysis (TGA) were taken by
Thermogravimetric analyzer METTLER TOLEDO from room
temperature to 800 C under nitrogen flow to investigate
thermal decomposition experiments. The mechanical strength
of the nanofibrous scaffolds was assessed by a tensile testing
machine (INSTRON-5566, Elancourt, France). Nano Model
(Tehran, Iran) with two nozzles was used to electrospinning
experimental setup. Optical contact angle measuring instru-
ment OCA 15 plus model, was used to water contact assay.
Results and discussion
This study mainly focused on enhanced Osteogenic
Differentiation of Human Adipose Tissue Stem Cells by pH-
sensitive delivery of dexamethasone and investigation of
Poly-l-lactic acid Scaffold incorporated Chitosan coated
Mesoporous Silica Nanoparticles as pH-sensitive composite
on the ability of the nanofiber scaffolds to support and facili-
tate osteogenic differentiation of MSCs. Scheme 1 shows
schematic representation for the Poly-l-lactic acid Scaffold
incorporated Dexa loaded Chitosan coated Mesoporous Silica
Nanoparticles.
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Characterization of MSNs
FT-IR analysis
As shown in Figure 1(A), FT-IR spectra of MSN showed
absorption peak at around 1060 cm1 is attributed to Si–O–Si
(mSi–O–Si) bond and absorption peaks around 963 cm
1 and
800 cm1 are attributed to the stretching vibration of Si–OH
(mSi–OH) and Si–O (mSi–O), respectively. The peak appeared at
around 2900 cm1 is relating to the C–H stretching vibrations
(mCH) which disappeared after calcination of MSN. The peak
appeared in the spectrum of CS coated MSNs at around
2900 cm1 is attributed to C–H stretching vibrations (mCH)
and could be ascribed to CS coating layer on the surface of
CS coated MSN. In the spectrum of chitosan, the band
appeared at around 2900 cm1 is attributed to the stretching
vibration of C–H and all other bands are the same with the
FTIR spectrum of CS [31].
Morphological analysis of MSN
The Morphological analysis of MSN and MSN@CS are shown
in Figure 2 Spherical shape and proper size distribution of
prepared MSN could be seen clearly. Presence of the CS layer
on the surface of MSN has been shown in Figure 2(b,d).
Classified pores and hexagonal array MSN networks could be
seen in the TEM image (Figure 2(c)). As shown in Figure 2(d),
CS layer around the MSN core could be perceived.
XRD analysis
The XRD pattern of MSN and MSN@CS after remove template
confirmed the crystalline structure of MSN and MSN@CS. As
shown in XRD pattern (Figure 1(B)), the presence of CS on
the surface of MSN could preserve a slight decrease in the
intensity in comparison with MSN. The results are in
accordance with published reports [29,31,33] and confirmed
the formation of hexagonal structure of MSN.
Thermogravimetric analysis (TGA)
In order to gain some structural information about surface
modification and determination of percentage of CS coated
layer on the surface of MSNs, TGA analysis under a constant
N2 flow was performed. As shown in Figure 1(C), two-step of
losing weight have been seen over the thermogram of CS
coated MSN. First one in the range of 25–150 C indicating
the evaporation of residual solvent and adsorbed water that
led to a weight loss percentage of about 15% and the
another one in the range of 150–500 C could be assigned to
the removal of CS coating layer on the surface of MSNs that
led to a total weight loss percentage of about 25%.
Dexa loading into MSN
In order to investigate Dexa loading efficiency (DLE) and DOX
loading capacity (DLC) as two more important parameters of
capability of the carrier. UV-visible spectroscopy was used to
calculate amount of Dexa loaded in MSN pores by using
Standard calibration curve of Dexa in DI water (Figure 1(D)).
The drug loading in MSN is directly influenced by the pore
size [37]. The calculated result showed 2.4 and 14.4% for DLC
and DLE, respectively.
Morphological analysis of scaffolds
As shown in Figure 3 both PLLA and MSN-Dexa@CS/PLLA
scaffolds are porous, with interconnected pore between the
nanofibers. The image analysis of the nanofibers by Image J
software showed a mean diameter of 565 ± 353 nm for PLLA
and 783 ± 342 nm for MSN-Dexa@CS/PLLA scaffolds. This
shows that the incorporation of the MSN-Dexa@CS/PLLA to
PLLA significantly changed the fiber diameter of the nanofib-
ers. However, it couldn’t bring any significant change in the
porosity and pore size of the scaffold. The change in fiber
diameter was attributed to change in solution property of
the electrospun solution after the addition of MSN-Dexa@CS/
PLLA, which increases the viscosity and decreased the electric
conductivity of the solution [38].
Tensile strength
The tensile strength of a nanofibrous scaffold is one of the
most common parameters for evaluation of scaffolds used in
tissue engineering. Since the scaffolds need to resist stress
imposed during in vitro cell culture and in vivo implantation
[39]. As shown in Figure 4, Pure PLLA scaffolds here have a
tensile stress of 2.8 ± 0.2MPa and a breaking tensile strain of
193%, which has been changed to 5.2 ± 0.2MPa and 83% in
MSN-Dexa@CS/PLLA. Hence, addition of MSN-Dexa@CS sig-
nificantly increased the mechanical strength of pure
PLLA scaffolds.
Scheme 1. Schematic representation for the PLLA Scaffold incorporated
MSN-Dexa@CS.
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Surface hydrophilicity
The water contact angle measurement is the method used to
determine the surface hydrophilicity of the nanofibrous scaf-
folds. In this work, to improve the surface hydrophilic the fab-
ricated scaffolds were air plasma treated. The water contact
angle of the scaffolds was changed from 130±1.8 to
42.0 ± 2.2 for PLLA scaffolds and to 24±1.6 after the add-
ition of MSN-Dexa@CS. Hence, addition of MSN-Dexa@CS
changed the surface hydrophilicity of pure PLLA scaffolds. The
surface wetting of scaffolds used in TE plays key role in deter-
mining the overall performance of their applications; because,
it affects the cell attachment and proliferation to great extent.
The water contact angle of the surface depends upon the
topographic configurations and chemical composition of the
scaffolds [40]. Hence, the presence of MSN-Dexa@CS had a
great impact on the hydrophilicity of the scaffolds.
Cell attachment and proliferation
The affinity of the cell for the fabricated scaffolds; which is
defined as adhesion and proliferation of cultured stem cells
was examined using MTT assay. As shown in Figure 5(a), the
cell attachment and proliferation was performed for 7 days:
at day 1 for cell attachment and at day 1, day 4 and day 7
for cell proliferation. The results demonstrated that all scaf-
folds were conductive and biocompatible. Moreover, similar
trend of cell growth was observed in all the tested dates for
all the scaffolds: cell number gradually increased with the
culture period from 1 to 7 days for all the scaffolds. However,
MSN@CS/PLLA composite scaffolds showed significantly the
largest number of cells than PLLA and MSN-Dexa@CS/PLLA
scaffolds (p< .05). But, there was no significant change in
cells population grown between MSN@CS/PLLA and MSN-
Dexa@CS/PLLA scaffolds in all the tested dates (p> .05).
Figure 1. FT-IR spectra of MSN (a) and calcinated MSN (b) (A), XRD pattern of MSN (a) and MSN@CS (b) after the removal of template (B), TGA Thermogram of CS
coated MSN (C) and Standard calibration curve of Dexa in DI water (D).
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Osteogenic differentiation
The ability of the nanofiber scaffolds (PLLA, MSN@CS/PLLA
and MSN-Dexa@CS/PLLA) to support and facilitate osteogenic
differentiation of MSC was investigated by measuring the
quantity of bone-related markers such as alkaline phosphat-
ase activity and calcium deposition (mineralization). Herein,
the effect of nanoparticle containing Dexa released from the
composite scaffold (MSN-Dexa@CS/PLLA) on MSCs after 7, 14
and 21-day cultures was investigated (Figure 5(b,c)), and the
results were compared with pure PLLA scaffolds and compos-
ite scaffolds without Dexa (MSN@CS/PLLA). ALP activity is an
early marker of osteogenic differentiation of human MSCs.
Figure 2. FE-SEM images of MSNs-calcinated (a), MSN@CS (b), TEM images of MSNs-calcinated (c) and MSN@CS (d).
Figure 3. SEM Picture of scaffolds: PLLA (a), MSN-Dexa@CS/PLLA Composite (b).
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It increases but then decreases when the culture becomes
well-mineralized. ALP activity of MSCs cultured in osteogenic
conditions usually peaks after 7–14 days, depending on cell
sources and culture conditions [41]. ALP activity of adipose
tissue-derived MSCs seeded on the scaffolds and TCP were
conducted for 21 days (at the 7th, 14th and 21st day of cul-
ture). As shown in Figure 5(b) an increase in ALP activity was
observed for cells cultured on the TCP and the 3 scaffolds
(PLLA, MSN@CS/PLLA and MSN-Dexa@CS/PLLA) and from day
7 till day 14. But, then decrease at the 21st date of study.
The level of calcium deposition was measured for 21 days
to further evaluate the osteogenic differentiation on the dif-
ferent scaffolds (PLLA, MSN@CS/PLLA and MSN-Dexa@CS/
PLLA). As shown in Figure 5(c), a similar trend of increase in
calcium level deposition was observed from day 7 to day 14
and then day 21. On day 7 and 14, the level of calcium
deposition in all the scaffolds was significantly greater than
that of TCP. However, on the 21st day, MSN@CS/PLLA and
MSN-Dexa@CS/PLLA scaffolds showed a comparable level of
calcium deposition with TCP; but, significantly greater than
pure PLLA scaffolds (p< .05). Hence, the composite scaffolds
exhibited statistically significant (p< .05) level of calcium
deposition which strongly supported the osteogenic differen-
tiation of MSCs, which also indicated that there was a con-
trolled release of nanoparticle containing Dexa from the
composite scaffolds that revealed enhanced osteoblast differ-
entiation capacity of the targeted delivery system. For the
regeneration of bone, bioactive inorganic phases have been
attractive through providing chemical and/or physical bone
bioactive cues to the cells involved in osteogenic processes.
However, Inorganic nanofibers have poor mechanical stability
needing significant improvement to be effectively used as
cell supporting matrices. On the other hand, polymeric nano-
fibers provide adequate structural support, but their surface
needs to be improved to favor biological reactions, such as
cellular recognition and osteogenesis [31]. The addition of
chitosan-coated MSN significantly changed the physicochemi-
cal and mechanical properties of PLLA in a way that brings
Figure 5. Rate of cell proliferation of MSCs on different scaffolds and TCP (a), ALP activity of MSCs on different scaffolds and TCP (b) and Level of calcium deposition
of MSCs on different scaffolds and TCP (c).
Figure 4. Tensile strength graph of Pure PLLA and MSN-Dexa@CS/
PLLA scaffolds.
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favorable interfaces for MSCs proliferation and osteogenic dif-
ferentiation. This was mainly possible due to the presence of
a bunch of highly negatively charged silanol groups intro-
duced on the surface, which strongly attract calcium ions fol-
lowed by subsequent deposition of phosphate ions to form
calcium phosphate minerals. Not only the chemical charge
effect but also the highly enhanced surface area due to mes-
oporosity can account for the substantially enhanced surface
bone bioactivity of the nanofibers. While the composite scaf-
folds played an effective role as a matrix for stem cell behav-
ior toward bone, they also showed additional important
performance in targeted drug delivering at the implantation
site [42]. According to the previous studies, this good MSCs
proliferation and enhanced in vitro osteoinductivity of the
composite scaffolds may also be related to the natural prop-
erties of CS [31].
Conclusion
In this study, we successfully fabricated a composite nanofi-
brous scaffold of MSN-Dexa@CS/PLLA for pH-sensitive deliv-
ery of Dexa to enhance bone regeneration. The fabricated
scaffolds have appropriate surface characteristics and mech-
anical properties with enhanced MSCs proliferation and
osteogenic differentiation compared with pure PLLA nanofi-
brous scaffolds. Hence, this scaffolds can be used simultan-
eously for targeted drug delivery in bone tissue engineering
application. However, further in vivo study is required to
demonstrate their application in the ideal condition.
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